logo
CanyamYour research section headline
language
MobileMobile
  • Phone FeatureWeChat Mini Program
    • EnglishEnglish
    noticeNotice
    BlogBlog
    delete
    arrow
    Return

    Interplay of HDL cholesterol and apoB and the risk of incident atherosclerotic cardiovascular disease in UK Biobank

    delete2026-07-31
    delete0
    delete
    OA
    AI
    A
    Allan Sniderman, MD *
    K
    Karol Pencina, PhD
    G
    George Thanassoulis
    L
    Line Dufresne, MSc
    M
    Michael Pencina, PhD
    DOI：10.1093/eurjpc/zwag400delete
    deleteOriginal
    deleteOriginal request for help
    deleteShare
    deleteSave
    Abstract

    Abstract

    En 中文
    Apolipoprotein B (apoB) is the most accurate causal lipid factor associated with increased risk of atherosclerotic cardiovascular disease (ASCVD). While high HDL cholesterol has been considered protective, HDL-C–raising therapies have not shown benefit.

    Journal

    European Journal of Preventive Cardiology cover
    European Journal of Preventive Cardiology
    IF:
    7.5
    Papers:
    5.8K
    Citations:
    1.2W

    Organization

    M
    mcgill university health centre
    Scholars:
    563
    Papers: 259
    Citations: 0